Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224048 · ClinicalTrials.gov registry record · Phase 4
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
A Phase 4 study of Gastric Cancer and H. Pylori Infection, sponsored by University of Miami.
- Active
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT07224048 is a Phase 4 study of Gastric Cancer and H. Pylori Infection that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 75 participants, below the 319-participant average among 153 other Gastric Cancer trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07224048, a Phase 4 study of Gastric Cancer and H. Pylori Infection, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there is an opportunity to prevent gastritis, peptic ulcer disease, and even gastric cancer.
Conditions Studied
Interventions
- DRUG PYTEST® 14C-Urea Capsule Breath Test (at Home)
- DRUG PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person)
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2027-11-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07224048
The ClinicalTrials.gov registry entry for NCT07224048 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 319-participant average among 153 other Gastric Cancer trials with a reported enrollment target (76% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastric Cancer appearing as the primary indexed condition, and to 2 interventions - of which PYTEST® 14C-Urea Capsule Breath Test (at Home) is the first listed.
NCT07224048 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07224048 about?
NCT07224048 is a clinical study titled "Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2". H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there...
What is the current status of trial NCT07224048?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2024-11-06. Estimated completion is 2027-11-06.
What conditions does trial NCT07224048 study?
This clinical trial studies the following conditions: Gastric Cancer, H. Pylori Infection, Gastritis H Pylori.
What interventions are being tested in trial NCT07224048?
The interventions under investigation include: PYTEST® 14C-Urea Capsule Breath Test (at Home) (DRUG), PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) (DRUG).
Who is sponsoring clinical trial NCT07224048?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224048 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RECRUITING · Phase 4
-
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1
ACTIVE NOT RECRUITING · Phase 4
-
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
COMPLETED · Phase 4
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.